Biologicals

Syngenta Group reports $32.2 billion sales and $4.6 billion EBITDA in 2023

Retrieved on: 
Mercoledì, Aprile 10, 2024
HTC, CER, Farmer, Pressure, Farm, Growth, Nutrition, Biologicals, Crop protection, Flower, Shanghai Stock Exchange, Syngenta, Acquisition, IPO, Seed, MAP, Soil, Huludao, Fine chemical

Full-year sales of Syngenta Crop Protection were 5 percent lower at $15.5 billion after exceptional growth in the previous year.

Key Points: 
  • Full-year sales of Syngenta Crop Protection were 5 percent lower at $15.5 billion after exceptional growth in the previous year.
  • ADAMA sales decreased 17 percent to $5.6 billion for the full year 2023, with significant channel destocking, particularly in the Americas, affecting the comparison.
  • Syngenta Seeds sales grew 2 percent to $4.8 billion in the full year 2023 in an overall growing seeds market.
  • Sales of Syngenta Group China, consisting of the Group’s Seeds, Crop Protection, Crop Nutrition, MAP and digital activities in China, grew 11 percent to $9.6 billion in the full year 2023.

Syngenta Group reports $32.2 billion sales and $4.6 billion EBITDA in 2023

Retrieved on: 
Venerdì, Marzo 29, 2024
Environmental Health, Organic Food, Agriculture, Other Science, Natural Resources, Research, Green Technology, Retail, Environment, Science, Sustainability, HTC, CER, Farmer, Pressure, Farm, Growth, Nutrition, Biologicals, Crop protection, Flower, Shanghai Stock Exchange, Syngenta, Acquisition, IPO, Seed, MAP, Soil, Huludao, Fine chemical

Full-year sales of Syngenta Crop Protection were 5 percent lower at $15.5 billion after exceptional growth in the previous year.

Key Points: 
  • Full-year sales of Syngenta Crop Protection were 5 percent lower at $15.5 billion after exceptional growth in the previous year.
  • ADAMA sales decreased 17 percent to $5.6 billion for the full year 2023, with significant channel destocking, particularly in the Americas, affecting the comparison.
  • Syngenta Seeds sales grew 2 percent to $4.8 billion in the full year 2023 in an overall growing seeds market.
  • Sales of Syngenta Group China, consisting of the Group’s Seeds, Crop Protection, Crop Nutrition, MAP and digital activities in China, grew 11 percent to $9.6 billion in the full year 2023.

Hamilton Thorne Appoints Dr. Ekaterina (Kate) Torchilin as President and CEO

Retrieved on: 
Giovedì, Dicembre 21, 2023
Tufts University, Purification, Software, Biologicals, Research, Acquisition, Cell culture, Cell, Connected health, Vaccine, ART, MBA, Thermo Fisher Scientific, Doctor of Philosophy, Harvard Business School, Health, Biochemistry, Growth, TSX, Patient, HTL, Management

Dr. Torchilin is succeeding David Wolf, who is retiring as President and CEO.

Key Points: 
  • Dr. Torchilin is succeeding David Wolf, who is retiring as President and CEO.
  • Dr. Torchilin will also join the Hamilton Thorne Board of Directors upon assuming the CEO role.
  • Hamilton Thorne Chairman David Wolf said: “We are delighted to welcome Kate as our new Chief Executive at this exciting time in our Company’s development.
  • He will also continue to work actively to develop acquisition initiatives and strategic stakeholder and industry relationships.

Global Facial Implant Market Fueled by Rising Virtual Representation on Social Media - Forecast 2023-2030

Retrieved on: 
Mercoledì, Agosto 16, 2023
Biologicals, Pressure, Metal, High, Research report, COVID-19, Consumer, Research, USD, Certification, Ceramic, Compound annual growth rate, Social impact assessment, Blepharoplasty, Investment, R, Polymer, Beauty salon, Tissue paper, Medical device, Rhinoplasty, Cheek, Procedure

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Facial Implant Market.

Key Points: 
  • The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Facial Implant Market.
  • What are the inhibiting factors and impact of COVID-19 shaping the Global Facial Implant Market during the forecast period?
  • Which are the products/segments/applications/areas to invest in over the forecast period in the Global Facial Implant Market?
  • What is the market share of the leading vendors in the Global Facial Implant Market?

Corteva Agriscience and Bioceres Crop Solutions to Advance Availability of Biologicals in Europe

Retrieved on: 
Martedì, Luglio 18, 2023
Sustainability, Technology, Agriculture, Agritech, Natural Resources, Genetics, Environment, Science, Chemicals, Plastics, Biotechnology, Health, Other Science, Manufacturing, Rape, Partnership, Corteva, Seed, Farmer, Agricultural science, Bachelor of Applied Technology, Pro, NYSE, Insecticide, Fertilizer, Biologicals, Genetically modified wheat

Corteva Agriscience (Corteva) (NYSE: CTVA) and Bioceres Crop Solutions Corp. (Bioceres) (NASDAQ: BIOX), announced today that they have entered into an exclusive agreement to advance the availability of biological solutions in Europe.

Key Points: 
  • Corteva Agriscience (Corteva) (NYSE: CTVA) and Bioceres Crop Solutions Corp. (Bioceres) (NASDAQ: BIOX), announced today that they have entered into an exclusive agreement to advance the availability of biological solutions in Europe.
  • Under the agreement, Corteva Agriscience and Bioceres Crop Solutions will work jointly to accelerate the regulatory processes required to bring a cutting-edge bioinsecticide developed by Bioceres’ subsidiary Pro Farm, to the European market.
  • Once registrations are secured, Corteva Agriscience will be the exclusive distributor in Europe, through their Seed Applied Technologies team and will also treat its Pioneer® brand seed products with the technology.
  • In addition, Corteva Agriscience will continue to commercialize Pro Farm’s Lumidapt™, a growth nutrition seed treatment for crops.

Corteva Reports First Quarter 2023 Results, Raises Full-Year Guidance

Retrieved on: 
Mercoledì, Maggio 3, 2023
Pressure, Biologicals, Farmer, Rapeseed, Agriculture, Bunge, AG, GAAP, Carbon, Grain, Fop, Corteva, Crop protection, Weed control, Soil, Investment, Herbicide, Growth, Weather, EPS, RNA interference, Health, Choline, Chevron Corporation, Pharmaceutical industry, Drug, Renewable energy

INDIANAPOLIS, May 3, 2023 /PRNewswire/ -- Corteva, Inc. (NYSE: CTVA) ("Corteva" or the "Company") today reported financial results for the three months ended March 31, 2023.

Key Points: 
  • First quarter 2023 net sales rose 6% versus prior year with gains in both segments.
  • GAAP income and earnings per share (EPS) from continuing operations were $607 million and $0.84 per share for the first quarter 2023, respectively.
  • "Corteva delivered a solid start to 2023, reflecting focused execution coupled with continued demand for our innovative technology solutions.
  • Corteva expects net sales in the range of $18.6 billion to $18.9 billion, growth of 7% at the mid-point.

Corteva Agriscience Completes Acquisitions of Symborg and Stoller

Retrieved on: 
Giovedì, Marzo 2, 2023
NYSE, EBITDA, Business, Farmer, Knowledge, Biologicals, Pharmaceutical industry, Agriculture, Corteva

INDIANAPOLIS, March 2, 2023 /PRNewswire/ -- Corteva, Inc. (NYSE: CTVA) cements its position as a global leader in the rapidly expanding Biologicals market with today's announcement that it has closed the acquisitions of Symborg, an expert in microbiological technologies based in Murcia, Spain; and Stoller, one of the largest independent companies in the Biologicals industry, based in Houston, Texas, U.S.

Key Points: 
  • "We are pleased to officially welcome Symborg and Stoller employees to Corteva.
  • Corteva first collaborated with Symborg to scale up and bring farmers Utrisha™ N and BlueN™ nutrient efficiency optimizers under a distribution agreement between the two companies.
  • Symborg possesses a diversified portfolio, emerging biocontrol pipeline, and skilled employees with robust technical knowledge and demand generation expertise.
  • The acquisitions of Symborg and Stoller were announced in the second half of 2022.

Certis Biologicals Introduces Kocide® 50DF; Powerful New Formulation of the Copper BioFungicide Trusted for Generations

Retrieved on: 
Giovedì, Febbraio 2, 2023
Agriculture, Natural Resources, Sustainability, Environment, Other Manufacturing, Chemicals, Plastics, Green Technology, Manufacturing, Canker, Blight, Copper, Vegetable, Phytophthora, Education, Citrus, Biologicals, IPM, Social media, Certis Group

Certis Biologicals today launched the newest copper product in the market, Kocide® 50DF (copper hydroxide).

Key Points: 
  • Certis Biologicals today launched the newest copper product in the market, Kocide® 50DF (copper hydroxide).
  • The premium high-load copper biofungicide can serve as both a preventative and curative product to combat a variety of fungal plant diseases, including blight, anthracnose, crown, canker, phytophthora and rot.
  • “We know that growers have trusted Kocide for generations to protect their crops and their livelihoods,” says Amy O’Shea, President & CEO.
  • “Having a new high-load copper in our portfolio is something that the Certis sales and technical teams across the U.S. have eagerly anticipated.

Biostimulants Market worth $6.2 billion by 2027 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Giovedì, Gennaio 5, 2023
Seaweed, Agriculture, Insecticide, Insect, BASF SE, Revolution, Climate, LDC, USD, FMC Corporation, UPL (company), Nature, Growth, Soil, Weather, Infestation, FMC, Water retention, Pesticide, Green Revolution, Farmer, Polysaccharide, Vegetable, Function, Crop protection, Nutrient, Health, Biostimulation, DuPont, Hormone, BASF, Livestock, Flood, Environment, Microbial inoculant, SE, Ministry of Health, Nutrition and Indigenous Medicine, Ion, Lithium, Plant, Dry, Acquisition, Absorption, Biologicals, Region, Herbicide, Fertility, Drought, Disaster, Fertilizer, Developing country, FAOSTAT, Fruit, Micronutrient, Maximal and minimal elements, Climate change, Limited

CHICAGO, Jan. 5, 2023 /PRNewswire/ -- The Biostimulants Market is estimated to be valued at USD 3.5 billion in 2022.

Key Points: 
  • CHICAGO, Jan. 5, 2023 /PRNewswire/ -- The Biostimulants Market is estimated to be valued at USD 3.5 billion in 2022.
  • It is projected to reach USD 6.2 billion by 2027, recording a CAGR of 11.8% from 2022 to 2027 according to a new report by MarketsandMarkets™.
  • The ease of application of foliar spray is one of the key drivers for growth in the market.
  • The key players in this market include BASF SE (Germany), UPL Limited (India), Adama Ltd. (Israel) and FMC Corporation (US).

Biostimulants Market worth $6.2 billion by 2027 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Giovedì, Gennaio 5, 2023
Seaweed, Agriculture, Insecticide, Insect, BASF SE, Revolution, Climate, LDC, USD, FMC Corporation, UPL (company), Nature, Growth, Soil, Weather, Infestation, FMC, Water retention, Pesticide, Green Revolution, Farmer, Polysaccharide, Vegetable, Function, Crop protection, Nutrient, Health, Biostimulation, DuPont, Hormone, BASF, Livestock, Flood, Environment, Microbial inoculant, SE, Ministry of Health, Nutrition and Indigenous Medicine, Ion, Lithium, Plant, Dry, Acquisition, Absorption, Biologicals, Region, Herbicide, Fertility, Drought, Disaster, Fertilizer, Developing country, FAOSTAT, Fruit, Micronutrient, Maximal and minimal elements, Climate change, Limited

CHICAGO, Jan. 5, 2023 /PRNewswire/ -- The Biostimulants Market is estimated to be valued at USD 3.5 billion in 2022.

Key Points: 
  • CHICAGO, Jan. 5, 2023 /PRNewswire/ -- The Biostimulants Market is estimated to be valued at USD 3.5 billion in 2022.
  • It is projected to reach USD 6.2 billion by 2027, recording a CAGR of 11.8% from 2022 to 2027 according to a new report by MarketsandMarkets™.
  • The ease of application of foliar spray is one of the key drivers for growth in the market.
  • The key players in this market include BASF SE (Germany), UPL Limited (India), Adama Ltd. (Israel) and FMC Corporation (US).